Insider Shareholders with Direct Ownership of Entasis Therapeutics Holdings Inc. (ETTX)
This section provides a comprehensive overview of the insiders with direct ownership of Entasis Therapeutics Holdings Inc. (ETTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Entasis Therapeutics Holdings Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
2,181,843 | 0 | 2,181,843 $0 | 1 |
Sep 28, 2018
Added 33.31%
|
|
Michael Gutch
Officer |
175,000 | 7,428 | 167,572 $0 | 5 |
Jan 18, 2022
Added 42.72%
|
|
David Altarac
Chief Medical Officer |
175,000 | 175,000 | 0 $0 | 7 |
Jul 11, 2022
Reduced 100.0%
|
|
Heather A. Berger
Director |
49,500 | 49,500 | 0 $0 | 4 |
Jul 11, 2022
Reduced 100.0%
|
|
David C Hastings
Director |
49,500 | 49,500 | 0 $0 | 4 |
Jul 11, 2022
Reduced 100.0%
|
|
Elizabeth M Keiley
General Counsel |
175,000 | 175,000 | 0 $0 | 7 |
Jul 11, 2022
Reduced 100.0%
|
|
Howard Mayer
Director |
49,500 | 49,500 | 0 $0 | 4 |
Jul 11, 2022
Reduced 100.0%
|
|
David D. Meek
Director |
49,500 | 49,500 | 0 $0 | 4 |
Jul 11, 2022
Reduced 100.0%
|
|
John Patrick Mueller
Chief Development Officer |
175,000 | 175,000 | 0 $0 | 7 |
Jul 11, 2022
Reduced 100.0%
|
|
Manoussos Perros
President and CEO |
284,500 | 558,250 | 0 $0 | 7 |
Jul 11, 2022
Reduced 100.0%
|
|
Matthew Ronsheim
Chief of Pharma Sciences & MFG |
175,000 | 175,000 | 0 $0 | 7 |
Jul 11, 2022
Reduced 100.0%
|
|
Ruben Tommasi
Chief Scientific Officer |
175,000 | 197,024 | 0 $0 | 7 |
Jul 11, 2022
Reduced 100.0%
|
|
Anna Diaz Triola
Chief Commercial Officer |
125,000 | 125,000 | 0 $0 | 2 |
Jul 11, 2022
Reduced 100.0%
|
|
Kristie Ann Wagner
VP, Principal Fin & Acct Off |
10,000 | 80,500 | 0 $0 | 2 |
Jul 11, 2022
Reduced 100.0%
|